Advanced Biomed Inc. Comm... (ADVB)
1.73
0.02 (1.17%)
At close: Apr 14, 2025, 12:29 PM
1.17% (1D)
| Bid | 1.71 |
| Market Cap | 37.42M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.11 |
| PE Ratio (ttm) | -15.72 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 1.73 |
| Volume | 164,474 |
| Avg. Volume (20D) | 116,048 |
| Open | 1.87 |
| Previous Close | 1.71 |
| Day's Range | 1.71 - 2.20 |
| 52-Week Range | 1.47 - 4.10 |
| Beta | 0.00 |
About ADVB
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies and provides them for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, a fully automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor ...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Mar 6, 2025
Employees 40
Stock Exchange NASDAQ
Ticker Symbol ADVB
Website https://www.advanbiomed.com